{"entity":{"id":"lungevity","kind":"collection","name":"LUNGevity Foundation (and GO2 for Lung Cancer)","aka":[],"tldr":"LUNGevity is the largest US lung cancer charity, focused on making sure every patient gets comprehensive biomarker testing and access to targeted therapy and trials, with a screening-advocacy partner in GO2.","summary":"LUNGevity (founded 2001) runs 'No One Missed' biomarker testing campaigns, patient education for each driver (EGFR, ALK, ROS1, KRAS G12C, MET, RET, HER2, NTRK, BRAF), the Lung Cancer Registry patient-reported research platform, HOPE Summits for survivors, and translational research awards. GO2 for Lung Cancer (Bonnie J. Addario Lung Cancer Foundation + Lung Cancer Alliance) runs the Centers of Excellence network for screening and care. Driver-specific patient groups (ALK Positive, EGFR Resisters, ROS1ders, KRAS Kickers, MET Crusaders) have become influential research partners.","asOf":"2026-09-08","links":[{"label":"LUNGevity","url":"https://www.lungevity.org/"},{"label":"GO2 for Lung Cancer","url":"https://go2.org/"},{"label":"ALK Positive","url":"https://www.alkpositive.org/"}],"tags":["gap-fill","patient-org"],"related":["nsclc","sclc","low-dose-ct-screening","egfr","alk","kras","ros1","cgp"],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":["companion-diagnostic-term"],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"url":"https://www.lungevity.org/","holds":"Biomarker testing education, the Lung Cancer HELPLine, patient-facing trial finder, survivorship programmes, research awards, and the Lung Cancer Registry; GO2 runs the Centers of Excellence and screening advocacy.","license":"Copyright LUNGevity","maintainer":"LUNGevity Foundation"},"route":"/collections/lungevity/","neighbours":{"cancer":[{"id":"nsclc","kind":"cancer","name":"Non-small-cell lung cancer","route":"/cancers/nsclc/"},{"id":"sclc","kind":"cancer","name":"Small-cell lung cancer","route":"/cancers/sclc/"}],"technology":[{"id":"cgp","kind":"technology","name":"Comprehensive genomic profiling","route":"/technologies/cgp/"},{"id":"low-dose-ct-screening","kind":"technology","name":"Low-dose CT lung screening","route":"/technologies/low-dose-ct-screening/"}],"target":[{"id":"alk","kind":"target","name":"ALK","route":"/targets/alk/"},{"id":"egfr","kind":"target","name":"EGFR","route":"/targets/egfr/"},{"id":"kras","kind":"target","name":"KRAS","route":"/targets/kras/"},{"id":"ros1","kind":"target","name":"ROS1","route":"/targets/ros1/"}],"term":[{"id":"companion-diagnostic-term","kind":"term","name":"Companion diagnostic","route":"/terms/companion-diagnostic-term/"}],"institution":[{"id":"iaslc","kind":"institution","name":"International Association for the Study of Lung Cancer","route":"/institutions/iaslc/"}]}}